Compile Data Set for Download or QSAR
Report error Found 230 Enz. Inhib. hit(s) with all data for entry = 9852
TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493323(US10981917, Example 24)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493339(US10981917, Example 43 | US10981917, Example 40)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493339(US10981917, Example 43 | US10981917, Example 40)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493345(US10981917, Example 46)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493357(US10981917, Example 58)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493360(US10981917, Example 61)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493362(US10981917, Example 63)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493363(US10981917, Example 64)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493366(US10981917, Example 67)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493368(US10981917, Example 69)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493369(US10981917, Example 70)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493378(US10981917, Example 79)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493379(US10981917, Example 80)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493382(US10981917, Example 83)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493388(US10981917, Example 89)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493390(US10981917, Example 91)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493396(US10981917, Example 97)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493398(US10981917, Example 99)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493400(US10981917, Example 101)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493403(US10981917, Example 104)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493408(US10981917, Example 109)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493410(US10981917, Example 111)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493415(US10981917, Example 116)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493473(US10981917, Example 174)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493481(US10981917, Example 182)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493486(US10981917, Example 187)
Affinity DataIC50: 100nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493300(US10981917, Example 1)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493301(US10981917, Example 2)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493303(US10981917, Example 4)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493304(US10981917, Example 5)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493306(US10981917, Example 7)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493309(US10981917, Example 10)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493310(US10981917, Example 11)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493311(US10981917, Example 12)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493314(US10981917, Example 15)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493315(US10981917, Example 16)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493322(US10981917, Example 23)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493326(US10981917, Example 27)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493327(US10981917, Example 28)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493329(US10981917, Example 30)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493330(US10981917, Example 31)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493331(US10981917, Example 32)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493332(US10981917, Example 33)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493333(US10981917, Example 34)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493334(US10981917, Example 35)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493335(US10981917, Example 36)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493336(US10981917, Example 37)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493338(US10981917, Example 39)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493343(US10981917, Example 44)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

TargetRibose-phosphate pyrophosphokinase 1(Human)
Daewoong Pharmaceutical

US Patent
LigandPNGBDBM493344(US10981917, Example 45)
Affinity DataIC50: 300nMAssay Description:In order to confirm the biological activities of the compounds prepared in Examples, % inhibition or IC50 values of PRS enzyme (phosphoribosylpyropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/27/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 230 total ) | Next | Last >>
Jump to: